Literature DB >> 17928214

Cell-cell signaling via Eph receptors and ephrins.

Juha-Pekka Himanen1, Nayanendu Saha, Dimitar B Nikolov.   

Abstract

Eph receptors are the largest subfamily of receptor tyrosine kinases regulating cell shape, movements, and attachment. The interactions of the Ephs with their ephrin ligands are restricted to the sites of cell-cell contact since both molecules are membrane attached. This review summarizes recent advances in our understanding of the molecular mechanisms underlining the diverse functions of the molecules during development and in the adult organism. The unique properties of this signaling system that are of highest interest and have been the focus of intense investigations are as follows: (i) the signal is simultaneously transduced in both ligand-expressing cells and receptor-expressing cells, (ii) signaling via the same molecules can generate opposing cellular reactions depending on the context, and (iii) the Ephs and the ephrins are divided into two subclasses with promiscuous intrasubclass interactions, but rarely observed intersubclass interactions.

Mesh:

Substances:

Year:  2007        PMID: 17928214      PMCID: PMC3327877          DOI: 10.1016/j.ceb.2007.08.004

Source DB:  PubMed          Journal:  Curr Opin Cell Biol        ISSN: 0955-0674            Impact factor:   8.382


  60 in total

1.  Modulation of EphA receptor function by coexpressed ephrinA ligands on retinal ganglion cell axons.

Authors:  M R Hornberger; D Dütting; T Ciossek; T Yamada; C Handwerker; S Lang; F Weth; J Huf; R Wessel; C Logan; H Tanaka; U Drescher
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

Review 2.  Cell signaling by receptor tyrosine kinases.

Authors:  J Schlessinger
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Crystal structure of an Eph receptor-ephrin complex.

Authors:  J P Himanen; K R Rajashankar; M Lackmann; C A Cowan; M Henkemeyer; D B Nikolov
Journal:  Nature       Date:  2001 Dec 20-27       Impact factor: 49.962

Review 4.  Mechanisms and functions of Eph and ephrin signalling.

Authors:  Klas Kullander; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2002-07       Impact factor: 94.444

5.  EphA receptor tyrosine kinases interact with co-expressed ephrin-A ligands in cis.

Authors:  Yanzhi Yin; Yukie Yamashita; Hirono Noda; Tatsuya Okafuji; Masahiro J Go; Hideaki Tanaka
Journal:  Neurosci Res       Date:  2004-03       Impact factor: 3.304

Review 6.  Targeting protein-protein interactions for cancer therapy.

Authors:  David C Fry; Lyubomir T Vassilev
Journal:  J Mol Med (Berl)       Date:  2005-11-11       Impact factor: 4.599

7.  Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans.

Authors:  Peter W Janes; Nayanendu Saha; William A Barton; Momchil V Kolev; Sabine H Wimmer-Kleikamp; Eva Nievergall; Carl P Blobel; Juha-Pekka Himanen; Martin Lackmann; Dimitar B Nikolov
Journal:  Cell       Date:  2005-10-21       Impact factor: 41.582

8.  Ephrin-A1 is expressed at sites of vascular development in the mouse.

Authors:  J L McBride; J C Ruiz
Journal:  Mech Dev       Date:  1998-10       Impact factor: 1.882

9.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

10.  Silencing of EphA3 through a cis interaction with ephrinA5.

Authors:  Ricardo F Carvalho; Martin Beutler; Katharine J M Marler; Bernd Knöll; Elena Becker-Barroso; R Heintzmann; Tony Ng; Uwe Drescher
Journal:  Nat Neurosci       Date:  2006-02-19       Impact factor: 24.884

View more
  117 in total

1.  Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection.

Authors:  Sayan Chakraborty; Mohanan Valiya Veettil; Virginie Bottero; Bala Chandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  Architecture of Eph receptor clusters.

Authors:  Juha P Himanen; Laila Yermekbayeva; Peter W Janes; John R Walker; Kai Xu; Lakmali Atapattu; Kanagalaghatta R Rajashankar; Anneloes Mensinga; Martin Lackmann; Dimitar B Nikolov; Sirano Dhe-Paganon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-26       Impact factor: 11.205

Review 3.  Eph/ephrin molecules--a hub for signaling and endocytosis.

Authors:  Mara E Pitulescu; Ralf H Adams
Journal:  Genes Dev       Date:  2010-11-15       Impact factor: 11.361

4.  Cooperativity between trans and cis interactions in cadherin-mediated junction formation.

Authors:  Yinghao Wu; Xiangshu Jin; Oliver Harrison; Lawrence Shapiro; Barry H Honig; Avinoam Ben-Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-27       Impact factor: 11.205

5.  Endothelial cells regulate cardiomyocyte development from embryonic stem cells.

Authors:  Kang Chen; Hao Bai; Melanie Arzigian; Yong-Xing Gao; Jing Bao; Wen-Shu Wu; Wei-Feng Shen; Liqun Wu; Zack Z Wang
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 6.  The role of Eph/ephrin molecules in stromal–hematopoietic interactions.

Authors:  Thao M Nguyen; Agnieszka Arthur; Stan Gronthos
Journal:  Int J Hematol       Date:  2016-02       Impact factor: 2.490

7.  EphA2 and Src regulate equatorial cell morphogenesis during lens development.

Authors:  Catherine Cheng; Moham M Ansari; Jonathan A Cooper; Xiaohua Gong
Journal:  Development       Date:  2013-09-11       Impact factor: 6.868

8.  Toward the semisynthesis of multidomain transmembrane receptors: modification of Eph tyrosine kinases.

Authors:  Nikhil Singla; Juha Pekka Himanen; Tom W Muir; Dimitar B Nikolov
Journal:  Protein Sci       Date:  2008-07-14       Impact factor: 6.725

Review 9.  The EphA2 receptor and ephrinA1 ligand in solid tumors: function and therapeutic targeting.

Authors:  Jill Wykosky; Waldemar Debinski
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

10.  Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma.

Authors:  Rebecca S Lescarbeau; Liang Lei; Katrina K Bakken; Peter A Sims; Jann N Sarkaria; Peter Canoll; Forest M White
Journal:  Mol Cancer Ther       Date:  2016-05-17       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.